Psyche

Researchers are examining whether participants' age may help explain why psychedelic studies reach different conclusions. Older adults may respond differently to psychedelic therapies than younger participants, which could account for variability across trials. The question matters as psychedelics move closer to regulated clinical use for depression and other mental health conditions.